Se‐Hoon Lee

33.1k citations
616 papers · 17.4k · 7 hit papers · h-index 67

Impact in

  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment

Papers in

    • Lung Cancer Treatments and Mutations 140
    • Lung Cancer Diagnosis and Treatment 26
    • Cancer Immunotherapy and Biomarkers 55
    • Lung Cancer Research Studies 55
    • Colorectal Cancer Treatments and Studies 22

Se‐Hoon Lee

579 papers receiving 17.2k citations

Se‐Hoon Lee's Hit Papers

Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer 2025 · 36 citations
360+5+11Years since publication100200300400500

Peers

Se‐Hoon Lee
Comparison fields: 5 of 188
  • Oncology 6.4k
  • Pulmonary and Respiratory Medicine 7.2k
  • Cancer Research 2.2k
  • Genetics 1.3k
  • Otorhinolaryngology 374
Replace Steven E. Schild with:
Steven E. Schild United States
Allan T. van Oosterom Belgium
Margaret Mooney United States
John Crowley United States
Patrick Schöffski Belgium
Nadia Howlader United States
C. Norman Coleman United States
David S. Hong United States
Lesley Seymour Canada
Keunchil Park South Korea
Se‐Hoon Lee relative to Steven E. Schild United States Steven E. Schild's profile →
Citations per field
00.5×1.5×2.1×
Steven E. Schild · 1×
Citations per year

Countries citing papers authored by Se‐Hoon Lee

Since Specialization
Citations

This map shows the geographic impact of Se‐Hoon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se‐Hoon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se‐Hoon Lee more than expected).

Fields of papers citing papers by Se‐Hoon Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se‐Hoon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se‐Hoon Lee. The network helps show where Se‐Hoon Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Se‐Hoon Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Se‐Hoon Lee Line = papers co-authored together Se‐Hoon Lee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 616 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Hit paper breakdown →
2023510
2
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Hit paper breakdown →
2009457
3 2012433
4
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Hit paper breakdown →
2019333
5 2017311
6
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Hit paper breakdown →
2019242
7
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Hit paper breakdown →
2018237
8 2005216
9 2015192
10 2019187
11 2011182
12 2017177
13 2016169
14 2016168
15 2019157
16 2015143
17 2017143
18 2005138
19 2013137
20 2019135

About Se‐Hoon Lee

Se‐Hoon Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 616 papers that have together received 17.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (140 papers), Cancer Immunotherapy and Biomarkers (55 papers), Lung Cancer Research Studies (55 papers), Cancer Genomics and Diagnostics (46 papers), Glioma Diagnosis and Treatment (44 papers), Lung Cancer Diagnosis and Treatment (26 papers), Radiomics and Machine Learning in Medical Imaging (25 papers) and Colorectal Cancer Treatments and Studies (22 papers). The work is most often cited by research in Oncology (6.4k citations), Pulmonary and Respiratory Medicine (7.2k citations), Cancer Research (2.2k citations), Genetics (1.3k citations) and Otorhinolaryngology (374 citations). Se‐Hoon Lee has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Keunchil Park, Jin Seok Ahn, Dae Seog Heo, Myung‐Ju Ahn, Tae Min Kim, Jong‐Mu Sun, Bhumsuk Keam, Dong‐Wan Kim, Doo Hyun Chung and Yung‐Jue Bang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Treatment, Lung Cancer, Journal of Thoracic Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact